Your browser doesn't support javascript.
loading
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay, Joël; Aupérin, Anne; Fayette, Jérôme; Saada-Bouzid, Esma; Lafond, Cédrik; Taberna, Miren; Geoffrois, Lionnel; Martin, Laurent; Capitain, Olivier; Cupissol, Didier; Castanie, Hélène; Vansteene, Damien; Schafhausen, Philippe; Johnson, Alison; Even, Caroline; Sire, Christian; Duplomb, Sophie; Evrard, Camille; Delord, Jean-Pierre; Laguerre, Brigitte; Zanetta, Sylvie; Chevassus-Clément, Cécile; Fraslin, Aldéric; Louat, Fanny; Sinigaglia, Laura; Keilholz, Ulrich; Bourhis, Jean; Mesia, Ricard.
Afiliação
  • Guigay J; Department of Medical Oncology and Research, Centre Antoine Lacassagne, FHU Oncoage, University Côte d'Azur, Nice, France. Electronic address: joel.guigay@nice.unicancer.fr.
  • Aupérin A; Biostatistic and Epidemiology Unit, Gustave Roussy, Oncostat 1018 INSERM, labeled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France.
  • Fayette J; Department of Medical Oncology, University of Lyon, Centre Léon Bérard, Lyon, France.
  • Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne, FHU Oncoage, University Côte d'Azur, Nice, France.
  • Lafond C; Department of Medical Oncology, ILC Centre Jean Bernard/Clinique Victor Hugo, Le Mans, France.
  • Taberna M; Department of Medical Oncology, Institut Català de Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Geoffrois L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France.
  • Martin L; Department of Medical Oncology, Clinique des Ormeaux, Le Havre, France.
  • Capitain O; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Paul Papin, Angers, France.
  • Cupissol D; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France.
  • Castanie H; Department of Medical Oncology, Hôpital Privé le Confluent, Sainte Catherine de Sienne, Nantes, France.
  • Vansteene D; Department of Medical Oncology, Institut de Cancérologie de l'Ouest René Gauducheau, Nantes, France.
  • Schafhausen P; Department of Medical Oncology, Universitätsklinikum Hamburg Eppendorf Hubertus Wald Tumorzentrum, Hamburg, Germany.
  • Johnson A; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Even C; Department of Head and Neck Oncology, Gustave Roussy, Villejuif, France.
  • Sire C; Department of Medical Oncology, Centre Hospitalier de Bretagne Sud, Lorient, France.
  • Duplomb S; Department of Medical Oncology, HCL, Hôpital de la Croix Rousse, Lyon, France.
  • Evrard C; Department of Medical Oncology, CHU, Université de Poitiers, Poitiers, France.
  • Delord JP; Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France.
  • Laguerre B; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Zanetta S; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Chevassus-Clément C; Biostatistic and Epidemiology Unit, Gustave Roussy, Oncostat 1018 INSERM, labeled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France.
  • Fraslin A; Biostatistic and Epidemiology Unit, Gustave Roussy, Oncostat 1018 INSERM, labeled Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France.
  • Louat F; GORTEC, Tours, France.
  • Sinigaglia L; GORTEC, Tours, France.
  • Keilholz U; Charité Comprehensive Cancer Center, Charité, Berlin, Germany.
  • Bourhis J; GORTEC, Tours, France.
  • Mesia R; Department of Medical Oncology, Institut Català de Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
Lancet Oncol ; 22(4): 463-475, 2021 04.
Article em En | MEDLINE | ID: mdl-33684370
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab / Carcinoma de Células Escamosas de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab / Carcinoma de Células Escamosas de Cabeça e Pescoço / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido